Use of EGFR transactivation inhibitors in human cancer
摘要
P OPER/HPM/Ma.Planck-Gesclischaf30691605/Div p.c doc-24/11/2008 5 The present invention relates to the use of a compound which is capable of inhibiting activation of a growth factor receptor of the EGFR-family for the prevention or treatment of processes associated with increased G-protein mediated signal transduction.
申请公布号
AU2008249216(B2)
申请公布日期
2012.01.19
申请号
AU20080249216
申请日期
2008.11.26
申请人
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
